478 related articles for article (PubMed ID: 29370315)
1. Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense.
Knight M; Braverman J; Asfaha K; Gronert K; Stanley S
PLoS Pathog; 2018 Jan; 14(1):e1006874. PubMed ID: 29370315
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis.
Braverman J; Sogi KM; Benjamin D; Nomura DK; Stanley SA
J Immunol; 2016 Aug; 197(4):1287-97. PubMed ID: 27430718
[TBL] [Abstract][Full Text] [Related]
3. Nitric Oxide Modulates Macrophage Responses to
Braverman J; Stanley SA
J Immunol; 2017 Sep; 199(5):1805-1816. PubMed ID: 28754681
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid oxidation of alternatively activated macrophages prevents foam cell formation, but Mycobacterium tuberculosis counteracts this process via HIF-1α activation.
Genoula M; Marín Franco JL; Maio M; Dolotowicz B; Ferreyra M; Milillo MA; Mascarau R; Moraña EJ; Palmero D; Matteo M; Fuentes F; López B; Barrionuevo P; Neyrolles O; Cougoule C; Lugo-Villarino G; Vérollet C; Sasiain MDC; Balboa L
PLoS Pathog; 2020 Oct; 16(10):e1008929. PubMed ID: 33002063
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α.
Van Dis E; Fox DM; Morrison HM; Fines DM; Babirye JP; McCann LH; Rawal S; Cox JS; Stanley SA
PLoS Pathog; 2022 Jul; 18(7):e1010721. PubMed ID: 35877763
[TBL] [Abstract][Full Text] [Related]
6. Metabolic adaptation to glycolysis is a basic defense mechanism of macrophages for Mycobacterium tuberculosis infection.
Osada-Oka M; Goda N; Saiga H; Yamamoto M; Takeda K; Ozeki Y; Yamaguchi T; Soga T; Tateishi Y; Miura K; Okuzaki D; Kobayashi K; Matsumoto S
Int Immunol; 2019 Nov; 31(12):781-793. PubMed ID: 31201418
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Lipid Droplet Proteomics Reveals Mycobacterium tuberculosis Induced Alterations in Macrophage Response to Infection.
Menon D; Singh K; Pinto SM; Nandy A; Jaisinghani N; Kutum R; Dash D; Prasad TSK; Gandotra S
ACS Infect Dis; 2019 Apr; 5(4):559-569. PubMed ID: 30663302
[TBL] [Abstract][Full Text] [Related]
8. Rab7 controls lipid droplet-phagosome association during mycobacterial infection.
Roque NR; Lage SL; Navarro R; Fazolini N; Maya-Monteiro CM; Rietdorf J; Melo RCN; D'Avila H; Bozza PT
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158703. PubMed ID: 32229179
[TBL] [Abstract][Full Text] [Related]
9. Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling.
Moreira-Teixeira L; Sousa J; McNab FW; Torrado E; Cardoso F; Machado H; Castro F; Cardoso V; Gaifem J; Wu X; Appelberg R; Castro AG; O'Garra A; Saraiva M
J Immunol; 2016 Dec; 197(12):4714-4726. PubMed ID: 27849167
[TBL] [Abstract][Full Text] [Related]
10. Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor.
Acosta-Iborra B; Elorza A; Olazabal IM; Martín-Cofreces NB; Martin-Puig S; Miró M; Calzada MJ; Aragonés J; Sánchez-Madrid F; Landázuri MO
J Immunol; 2009 Mar; 182(5):3155-64. PubMed ID: 19234213
[TBL] [Abstract][Full Text] [Related]
11. Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage.
Singh AK; Mukhopadhyay C; Biswas S; Singh VK; Mukhopadhyay CK
PLoS One; 2012; 7(6):e38489. PubMed ID: 22701652
[TBL] [Abstract][Full Text] [Related]
12. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma.
Nagabhushanam V; Solache A; Ting LM; Escaron CJ; Zhang JY; Ernst JD
J Immunol; 2003 Nov; 171(9):4750-7. PubMed ID: 14568951
[TBL] [Abstract][Full Text] [Related]
13. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
15. ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNγ-mediated autophagy and growth restriction of intracellular mycobacteria.
Lienard J; Movert E; Valfridsson C; Sturegård E; Carlsson F
Cell Microbiol; 2016 Oct; 18(10):1471-85. PubMed ID: 27062290
[TBL] [Abstract][Full Text] [Related]
16. Evidence for dispensability of protein kinase R in host control of tuberculosis.
Mundhra S; Bryk R; Hawryluk N; Zhang T; Jiang X; Nathan CF
Eur J Immunol; 2018 Apr; 48(4):612-620. PubMed ID: 29436711
[TBL] [Abstract][Full Text] [Related]
17. Immune control of tuberculosis by IFN-gamma-inducible LRG-47.
MacMicking JD; Taylor GA; McKinney JD
Science; 2003 Oct; 302(5645):654-9. PubMed ID: 14576437
[TBL] [Abstract][Full Text] [Related]
18. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
Shen P; Li Q; Ma J; Tian M; Hong F; Zhai X; Li J; Huang H; Shi C
BMC Microbiol; 2017 Aug; 17(1):185. PubMed ID: 28835201
[TBL] [Abstract][Full Text] [Related]
19. ESX Secretion-Associated Protein C From
Guo Q; Bi J; Li M; Ge W; Xu Y; Fan W; Wang H; Zhang X
Front Cell Infect Microbiol; 2019; 9():158. PubMed ID: 31134163
[No Abstract] [Full Text] [Related]
20. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.
Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR; Ernst JD
J Immunol; 2006 Mar; 176(5):3019-27. PubMed ID: 16493060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
